Aprea Therapeutics, Inc. SEC filings
| Form | Company | Filed | Accession |
|---|
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075286 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075284 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075283 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075282 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075281 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075280 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075279 |
| 4 | Aprea Therapeutics, Inc. | 2026-06-17 | 0001104659-26-075278 |
| 10-Q | Aprea Therapeutics, Inc. | 2026-05-13 | 0001104659-26-059743 |
| 4 | Aprea Therapeutics, Inc. | 2026-03-16 | 0001104659-26-028656 |
| 4 | Aprea Therapeutics, Inc. | 2026-03-16 | 0001104659-26-028653 |
| 10-K | Aprea Therapeutics, Inc. | 2026-03-16 | 0001104659-26-028068 |
| 4 | Aprea Therapeutics, Inc. | 2026-02-02 | 0001104659-26-009206 |
| 4 | Aprea Therapeutics, Inc. | 2026-02-02 | 0001104659-26-009203 |
| 4 | Aprea Therapeutics, Inc. | 2025-12-11 | 0001104659-25-120156 |
| 4 | Aprea Therapeutics, Inc. | 2025-12-11 | 0001104659-25-120155 |
| 10-Q | Aprea Therapeutics, Inc. | 2025-11-12 | 0001104659-25-109867 |
| 10-Q | Aprea Therapeutics, Inc. | 2025-08-12 | 0001558370-25-011152 |